CXL-1020

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CXL-1020, covering 2016-07-01 to 2016-11-15. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure [Phase 2]